NOT FOR REPRINT
Page Printed from: benefitspro.com/author/profile/caroline-chen-zachary-tracer/
Sign In To follow
Blood-testing startup Theranos has a plan to get U.S. regulators to review its offerings one by one, Chief Executive Officer Elizabeth Holmes said.
{ "author": { "name": "Caroline Chen Zachary Tracer", "webUrl": "/author/profile/caroline-chen-zachary-tracer/", "description": "", "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g", "estimate": 1, "social": [], "articles": [ { "uri": "/2015/10/19/theranos-limits-blood-technology-to-a-single-test/", "title": "Theranos limits blood technology to a single test out of 200", "byline": " Caroline Chen, Zachary Tracer ", "kicker": "", "prettyDate": "October 19, 2015", "timeToRead": "5 minute", "image": { "uri": "", "width": "", "height": "" }, "authors": [ { "webUrl": "/author/profile/caroline-chen-zachary-tracer/", "name": "Caroline Chen, Zachary Tracer" } ], "kickerNode": [], "summary": "Blood-testing startup Theranos has a plan to get U.S. regulators to review its offerings one by one, Chief Executive Officer Elizabeth Holmes said.", "body": null } ] } }